deucravacitinib, Placebo to match deucravacitinib tablet
IM011-054
Phase 3 small_molecule active
Quick answer
deucravacitinib, Placebo to match deucravacitinib tablet for Active Psoriatic Arthritis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Active Psoriatic Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active